Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia

Am J Hematol. 2018 Mar;93(3):467-468. doi: 10.1002/ajh.24894. Epub 2017 Sep 28.

Authors

Connie R Shi^{1

2}, Vinod E Nambudiri^{1

2

3}

Affiliations

¹ Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.

PMID: 28836284
DOI: 10.1002/ajh.24894

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Drug Eruptions / etiology*
Female
Hand Dermatoses / chemically induced
Humans
Imatinib Mesylate / adverse effects*
Imatinib Mesylate / therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Molecular Targeted Therapy
Protein Kinase Inhibitors / adverse effects*
Protein Kinase Inhibitors / therapeutic use
Scalp Dermatoses / chemically induced
Skin Diseases, Papulosquamous / chemically induced*

Substances

Antineoplastic Agents
Protein Kinase Inhibitors
Imatinib Mesylate